121 related articles for article (PubMed ID: 9105886)
1. Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes.
Debeir T; Vigé X; Benavides J
Eur J Pharmacol; 1997 Mar; 323(1):111-7. PubMed ID: 9105886
[TBL] [Abstract][Full Text] [Related]
2. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.
Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ
Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.
Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M
Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
5. Transduction mechanisms involved in thrombin receptor-induced nerve growth factor secretion and cell division in primary cultures of astrocytes.
Debeir T; Gueugnon J; Vigé X; Benavides J
J Neurochem; 1996 Jun; 66(6):2320-8. PubMed ID: 8632154
[TBL] [Abstract][Full Text] [Related]
6. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
[TBL] [Abstract][Full Text] [Related]
7. Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells.
Ubl JJ; Vöhringer C; Reiser G
Neuroscience; 1998 Sep; 86(2):597-609. PubMed ID: 9881872
[TBL] [Abstract][Full Text] [Related]
8. Development of potent thrombin receptor antagonist peptides.
Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
[TBL] [Abstract][Full Text] [Related]
9. Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes: evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand.
Ubl JJ; Sergeeva M; Reiser G
J Physiol; 2000 Jun; 525 Pt 2(Pt 2):319-30. PubMed ID: 10835036
[TBL] [Abstract][Full Text] [Related]
10. Dual effects of thrombin and a 14-amino acid peptide agonist of the thrombin receptor on septal cholinergic neurons.
Debeir T; Benavides J; Vigé X
Brain Res; 1996 Feb; 708(1-2):159-66. PubMed ID: 8720872
[TBL] [Abstract][Full Text] [Related]
11. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.
Wang H; Ubl JJ; Reiser G
Glia; 2002 Jan; 37(1):53-63. PubMed ID: 11746783
[TBL] [Abstract][Full Text] [Related]
12. Development of a potent thrombin receptor ligand.
Feng DM; Veber DF; Connolly TM; Condra C; Tang MJ; Nutt RF
J Med Chem; 1995 Sep; 38(20):4125-30. PubMed ID: 7562949
[TBL] [Abstract][Full Text] [Related]
13. Evidence that protease-activated receptor-2 mediates trypsin-induced reversal of stellation in cultured rat astrocytes.
Park GH; Ryu JR; Shin CY; Choi MS; Han BH; Kim WK; Kim HC; Ko KH
Neurosci Res; 2006 Jan; 54(1):15-23. PubMed ID: 16256233
[TBL] [Abstract][Full Text] [Related]
14. Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation.
Grabham P; Cunningham DD
J Neurochem; 1995 Feb; 64(2):583-91. PubMed ID: 7830051
[TBL] [Abstract][Full Text] [Related]
15. Thrombin receptor antagonists; recent advances in PAR-1 antagonist development.
Anderluh M; Dolenc MS
Curr Med Chem; 2002 Jul; 9(13):1229-50. PubMed ID: 12052165
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1.
Cavanaugh KP; Gurwitz D; Cunningham DD; Bradshaw RA
J Neurochem; 1990 May; 54(5):1735-43. PubMed ID: 1691280
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin.
Niego B; Samson AL; Petersen KU; Medcalf RL
Brain Res; 2011 Mar; 1381():38-51. PubMed ID: 21241677
[TBL] [Abstract][Full Text] [Related]
18. Thrombin mutants with altered enzymatic activity have an impaired mitogenic effect on mouse fibroblasts and are inefficient modulators of stellation of rat cortical astrocytes.
Arcone R; Pagliuca MG; Chinali A; Grimaldi M; Schettini G; Gast A; Pietropaolo C
Biochim Biophys Acta; 1999 Aug; 1451(1):173-86. PubMed ID: 10446399
[TBL] [Abstract][Full Text] [Related]
19. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
20. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
